Loading quotes...
Forecast
The analysts' average price target is €43.54 (+61.86%). The median is €43.54 (+61.86%).
| Buy |
4 |
| Hold |
0 |
| Sell |
0 |
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 314.29M | 17.46% |
| Gross profit | 269.27M | 25.40% |
| Net profit | 120.95M | 237.95% |
| EBITDA | 163.33M | 254.94% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €4.11B |
Number of shares | 124.77M |
52-week high/low | €38.84 - €10.05 |
Dividend yield | 27.00% |
Dividends TTM | €7.29 |
Beta | 1.11 |
P/E ratio | 8.12 |
PEG ratio | 0.05 |
P/B ratio | -58.45 |
P/S ratio | 1.26 |
Company profile
| Name | INDIVIOR PHARMACEUTICALS INC NPV |
| CEO | Joseph J. Ciaffoni |
| Employees | 833 |
